| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |